Billing and Coding: MolDX: Prostate Cancer Genomic Classifier Assay for Men with Localized Disease

The Prostate Genomic Classifier assay is billed for men with localized prostate cancer (ICD-10-CM C61) and complements LCD L38303. Claims must report the applicable CPT code with 1 unit of service, include the appropriate DEX Z-Code adjacent to the CPT code in the specified Part A or Part B claim fields, and list ICD-10-CM C61.

"Prostate Genomic Classifier assay is intended for men with localized prostate cancer (prostate malignancy)."

Sign up to see full coverage criteria, indications, and limitations.